| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/22/2004 | CA2490758A1 Dosage form of recombinant humanized monoclonal antibody 2c4 |
| 01/22/2004 | CA2489410A1 Molecular antigen arrays |
| 01/21/2004 | EP1382971A1 Detection of prion disease |
| 01/21/2004 | EP1382688A1 Screening method |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382617A1 Monoclonal antibodies recognizing human platelet GPIIIa and GPIIb/GPIIIa and use thereof in anti-thrombotic therapy |
| 01/21/2004 | EP1382615A1 MCAM inhibitors |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1381866A2 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 01/21/2004 | EP1381685A2 Genes and proteins for the biosynthesis of polyketides |
| 01/21/2004 | EP1381684A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/21/2004 | EP1381683A2 Human fibroblast growth factor-related compositions |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381631A2 Human timp-1 antibodies |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381628A2 Inflammation-specific peptides and the uses thereof |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381383A2 Methods of detecting multiple dna binding protein and dna interactions in a sample, and devices, systems and kits for practicing the same |
| 01/21/2004 | EP1010007B1 Collagen-peptide assay method |
| 01/21/2004 | EP0863982B1 Synthetic hpv11 virus-like particles |
| 01/21/2004 | EP0734263B1 ALPHAvBETA3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
| 01/21/2004 | EP0667786B1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 01/21/2004 | CN1469927A Enhancemnet of industrial production by increasing substrate transport |
| 01/21/2004 | CN1469926A Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2004 | CN1469925A Degraded TPO agonist antibody |
| 01/21/2004 | CN1469924A Degraded agonist antibody |
| 01/21/2004 | CN1468956A Recombinant virus of antibody for high-efficiency expression to treat tumor and its use |
| 01/21/2004 | CN1135114C Pigment mark poly-antibody and its preparing process |
| 01/21/2004 | CN1135113C Pigment marked polymerization antibody and preparation method thereof |
| 01/20/2004 | US6680376 Preferential isolation egg yolk antibodiesisoforms; obtain egg yolk, incubate with salt, recover antibody isoforms |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680366 Detecting antibodies; drug screening; genetic engineering |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680293 Prevention of membrane formation; obtain cell tissue, incubate with inhibitory collagen, monitor membrane formation |
| 01/20/2004 | US6680209 Analyzing samples containing human anti-mouse antibodies (hama) or heterophilic antibodies |
| 01/20/2004 | US6680192 Method for producing polymers having a preselected activity |
| 01/20/2004 | US6680189 (a disintegrin and metalloprotease) adam proteins; preventing or treating disc herniation, ischialgia, glomerular nephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis or osteoporosis |
| 01/20/2004 | US6680176 Antigen presenting cell; candidate ligand; analyzing the activation state as determined by the capacity to activate a killer t cell in the absence of a helper t cell |
| 01/20/2004 | US6680175 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | US6680170 Polynucleotides encoding STE20-related protein kinases and methods of use |
| 01/20/2004 | US6680168 Passive immunization against clostridium difficile disease |
| 01/20/2004 | US6680054 Macromolecular neuraminidase-binding compounds |
| 01/20/2004 | US6680053 Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same |
| 01/20/2004 | CA2115414C Technique for extracorporeal treatment of blood |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/20/2004 | CA2089212C Antibodies to human gastrin-releasing peptide precusor and use thereof |
| 01/20/2004 | CA2078235C Idiotypic vaccination against b cell lymphoma |
| 01/15/2004 | WO2004005931A1 Secreted polypeptide species associated with cardiovascular disorders |
| 01/15/2004 | WO2004005890A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 01/15/2004 | WO2004005540A2 Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases |
| 01/15/2004 | WO2004005531A2 Targeting and tracking of cells to specific organs and tissues in vivo |
| 01/15/2004 | WO2004005530A2 Compositions and methods for treatment and detection of multiple cancers |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005470A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | WO2004005468A2 Axs gene and protein and methods related thereto |
| 01/15/2004 | WO2004005457A2 Tfc/ beta-catenin regulated genes for treating cancer |
| 01/15/2004 | WO2004005351A2 Neoplasm specific antibodies and uses thereof |
| 01/15/2004 | WO2004005350A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 01/15/2004 | WO2004005349A2 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures |
| 01/15/2004 | WO2004005348A1 SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 |
| 01/15/2004 | WO2004005316A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 01/15/2004 | WO2004004770A1 Chemotactic factor inhibitor for modulating inflammatory reactions |
| 01/15/2004 | WO2004004768A1 Microparticle with cd28-specific monoclonal antibodies |
| 01/15/2004 | WO2004004767A1 Treatment of autoimmune diseases |
| 01/15/2004 | WO2004004765A1 Treatment of autoimmune skin diseases |
| 01/15/2004 | WO2004004764A1 Composition against white spot disease |
| 01/15/2004 | WO2004004756A1 Use of pthrp antagonists for treating renal cell carcinoma |
| 01/15/2004 | WO2004004662A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2004 | WO2004004642A2 TCELL TOLERANCE AND MODULATION OF AUTOIMMUNITY BY CD8α-CD4+ DENDRITIC CELLS |
| 01/15/2004 | WO2004004633A2 Use of tnfalpha antibodies and another drug |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2003099868A3 Method for obtaining anti-idiotype antibodies |
| 01/15/2004 | WO2003090513A3 Bi-specific antigen-binding compositions and related methods |
| 01/15/2004 | WO2003077943A3 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound |
| 01/15/2004 | WO2003063904A3 Tissue adhesion formation control |
| 01/15/2004 | WO2003059260A3 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 01/15/2004 | WO2003048083A3 Antibodies against monocyte chemotactic proteins |
| 01/15/2004 | WO2003046557A3 Hp biopolymer markers predictive of insulin resistance |
| 01/15/2004 | WO2003040169A3 Human monoclonal antibodies to dendritic cells |
| 01/15/2004 | WO2003037251A9 Hivgp120-induced bob/gpr15 activation |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003016467A3 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass |
| 01/15/2004 | WO2003006059A9 Vegfr-1 antibodies to treat breast cancer |
| 01/15/2004 | WO2002080966A8 Method for producing a vaccine containing autologous antibodies |
| 01/15/2004 | WO2002080888A3 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002057304A3 Secretory molecules |
| 01/15/2004 | WO2002046364A8 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010810 Producing xenogeneic monocolnal antibody for diagnosis and treatment of cancer, inflammation, allergies and asthma, autoimmune and cardiovascular diseases; immunotherapy |
| 01/15/2004 | US20040010376 Generation and selection of protein library in silico |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010125 Human immunodeficiency viral glycoprotein (HIV) for diagnosis, prevention and treatment of viral infection; genetic vaccines |
| 01/15/2004 | US20040010124 CD16A binding proteins and use for the treatment of immune disorders |